Oncology Analytics provides the critical missing link for health plans by helping to manage the total cost of cancer care. By providing access to current, evidence-based, disease-specific analytics on all cancer types and treatment options, backed by board-certified oncology physicians and pharmacists, health plans are able to provide their members with the ability to achieve the best possible outcomes.
Join the conversation
superwingy官网
优途加速器教程
![](http://qeucf.clickinresearch.com/wp-content/uploads/2023/05/eprior-auth-150x150.png)
e-Prior Authorization
Read More
![superwingy下载官网](http://qeucf.clickinresearch.com/wp-content/uploads/2023/05/Insights-150x150.png)
Oncology Insights™
Read More
![](http://qeucf.clickinresearch.com/wp-content/uploads/2023/05/pharm-150x150.png)
SuperWingy免费节点
Read More
优途加速器教程
![Oncology Analytics Raises $28 Million Series C Financing Led by Baird Capital](http://qeucf.clickinresearch.com/wp-content/uploads/2023/05/OA-linkedin-28.jpg)
优途加速器教程
National healthcare investor Baird Capital joins existing investors Oak HC/FT, McKesson Ventures and The Blue Venture Fund Atlanta, GA, May 26, 2023 — Oncology Analytics, a leading data analytics and technology-enabled services company dedicated to helping health...
![Oncology Analytics Appoints Dr. Andrew Norden As Chief Medical Officer](http://qeucf.clickinresearch.com/wp-content/uploads/2023/05/OA-linkedin-AN2.jpg)
优途加速器教程
Former Dana-Farber Associate Chief Medical Officer to Lead Company’s Clinical Team and Innovation Strategy
优途加速器教程
![JAVELIN Bladder 100 Phase III Results: Maintenance Avelumab + Best Supportive Case vs. BSC Alone After Platinum-Based First-Line Chemotherapy in Advanced Urothelial Carcinoma](http://qeucf.clickinresearch.com/wp-content/uploads/2023/07/MelissaP.jpg)
JAVELIN Bladder 100 Phase III Results: Maintenance Avelumab + Best Supportive Case vs. BSC Alone After Platinum-Based First-Line Chemotherapy in Advanced Urothelial Carcinoma
The following article, written by Melissa Pozotrigo, Senior Clinical Oncology Pharmacist at Oncology Analytics, is the final of a four-part series on key trends and findings from the 2023 American Society of Clinical Oncology (ASCO) Virtual Scientific Program, held May 29-31, 2023.
![#2 Leverage Real-World Data and Analytics](http://qeucf.clickinresearch.com/wp-content/uploads/2023/07/OA-linkedin-top5-2new.jpg)
#2 Leverage Real-World Data and Analytics
The following article is the fourth in a five-part series on The Top Five Ways for Health Plans to Manage Oncology Drug Costs While Improving Member Treatment Options.
Events
![](http://qeucf.clickinresearch.com/wp-content/uploads/2023/04/util4.jpg)
Utilization Management: Addressing Crucial Challenges for Health Plans
Date: October 20-21
Embassy Suites by Hilton
Fort Lauderdale, FL
![](http://qeucf.clickinresearch.com/wp-content/uploads/2023/12/webinar.jpg)
Is Prior Authorization the Best Approach for Oncology?
Available On-demand
Watch >>